1. Mao, R., Z. Liu, Y. Zhao, C. Du and J. Zhou et al., 2022. Stable chronic obstructive pulmonary disease (COPD) management under a tiered medical system in China. Int. J. Chronic Obstructive Pulm. Dis., 17: 181-194.
   CrossRef  |  Direct Link  |  
2. Liu, X., C. Du, F. Hu, Y. Zhao and J. Zhou et al., 2022. Management of acute exacerbation of chronic obstructive pulmonary disease under a tiered medical system in China. Ther. Adv. Respir. Dis., Vol. 16. 10.1177/17534666221075499.
   CrossRef  |  Direct Link  |  
3. Zhou, L., B. Wu, J. Yang, B. Wang, J. Pan, D. Xu and C. Du, 2021. Knockdown of circFOXO3 ameliorates cigarette smoke-induced lung injury in mice. Respir. Res., Vol. 22. 10.1186/s12931-021-01883-w.
   CrossRef  |  Direct Link  |  
4. Wang, S.M., F.Y. Zhang, C.L. Du, X.B. Wang and F. Li et al., 2021. Epidemiology and issues of NIV-treated AECOPD patients with hypercapnic respiratory failure in Shanghai: A multicentre retrospective survey. Clin. Respir. J., 15: 550-557.
   CrossRef  |  Direct Link  |  
5. Tao, Y., Y. Sun, B. Wu, D. Xu, J. Yang, L. Gu and C. Du, 2021. Overexpression of FOXA2 attenuates cigarette smoke-induced cellular senescence and lung inflammation through inhibition of the p38 and Erk1/2 MAPK pathways. Int. Immunopharmacol., Vol. 94. 10.1016/j.intimp.2021.107427.
   CrossRef  |  Direct Link  |  
6. Wu, C., X. Hu, J. Song, D. Yang and J. Xu et al., 2020. Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China. Clin. Transl. Med., Vol. 10. 10.1002/ctm2.52.
   CrossRef  |  Direct Link  |  
7. Wu, C., D. Hou, C. Du, Y. Cai and J. Zheng et al., 2020. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: A cohort study with propensity score analysis. Crit. Care, Vol. 24. 10.1186/s13054-020-03340-4.
   CrossRef  |  Direct Link  |  
8. Lu, J., L. Zhou, B. Wu, Y. Duan and Y. Sun et al., 2020. MiR-501-3p functions as a tumor suppressor in non-small cell lung cancer by downregulating RAP1A. Exp. Cell Res., Vol. 387. 10.1016/j.yexcr.2019.111752.
   CrossRef  |  Direct Link  |  
9. Bi, J., Z. Min, H. Yuan, Z. Jiang and R. Mao et al., 2020. PI3K inhibitor treatment ameliorates the glucocorticoid insensitivity of PBMCs in severe asthma. Clin. Transl. Med., Vol. 9. 10.1186/s40169-020-0262-5.
   CrossRef  |  Direct Link  |  
10. Yuan, H., X. Liu, L. Li, G. Wang and C. Liu et al., 2019. Clinical and pulmonary function changes in cough variant asthma with small airway disease. Allergy Asthma Clin. Immunol., Vol. 15. 10.1186/s13223-019-0354-1.
    CrossRef  |  Direct Link  |